"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT05322057","Efficacy of Cx601 (Darvadstrocel) for the Treatment of Perianal Fistulizing Crohn's Disease",,"Completed","No Results Available","Crohn Disease|Fistula Perianal","Drug: Darvadstrocel","Fistula Closure|Evaluation of perianal disease|Evaluation of Crohn's disease","Medical University of Vienna","All","18 Years to 90 Years Â  (Adult, Older Adult)",,"14","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","1682/2018","October 1, 2018","December 1, 2021","December 1, 2021","April 11, 2022",,"April 11, 2022","Medical University of Vienna, Vienna, Austria",,"https://ClinicalTrials.gov/show/NCT05322057"
